—
C+
C+ The full Closelook — membership. Open the C+ overview

Medacta Group SA (MOVE.SW) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Medacta Group SA

MOVE.SW in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Medacta designs, manufactures and distributes orthopaedic and neurosurgical devices, selling into Latin America, North America, Asia-Pacific and the Middle East and Africa. It builds personalised 3D planning tools used in hip, knee, shoulder and joint replacement, sports medicine and spine surgery. The company was founded in 1958 and is based in Castel San Pietro, Switzerland.
Where it sits in the stack
Medacta carries no seat in our Rubin index; it sits in the medical-device sleeve of our wider universe, under the Healthcare sector, rather than in any part of the AI build-out.
Who it is priced against
The diary has not built a peer group for this name; the comparison the market draws is with larger orthopaedic device makers such as Stryker.
Why Closelook tracks it
Medacta holds no index seat in our coverage and no Closelook score has been built for it. It does not appear in the quotes or editions the diary tracks.
What the diary watches
The diary watches whether procedure volumes in joint replacement and spine surgery grow, and whether the company's push into new regions turns into device sales.

Medacta Group SA (MOVE.SW) trades on the SW exchange in Switzerland, classified under Healthcare.

The Closelook company score reads 47/100 composite (momentum 10, quality 57, valuation 32) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for MOVE.SW, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Devices · 8 names with week and year-to-date

Peer group

Medical Devices

Names in the same industry from the Closelook universe; scored names rank on their Closelook score, the rest on trend state.

Compared against MOVE.SW on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 1.01%, annual · buybacks 6 m CHF in FY2025

Dividends and capital return

What MOVE.SW pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 1.10 CHF per share · a 1.01% yield on the 2026-09-18 close 1 distribution, paid once a year 2026-09-18
  • Change on the year +59.4% against the prior twelve months prior twelve months 0.69 CHF per share
  • Last distribution 1.10 CHF per share as the price series records it, within days of the ex-date 2026-05-07
  • By calendar year 2025: 0.69 CHF (partial) · 2026: 1.10 CHF to date first distribution recorded in the three-year window: 2025-05-09
  • Dividends paid, FY2025 15 m CHF 62% of earnings
  • Buybacks, FY2025 6 m CHF 0.3% of today's market value
  • Share count +0.3% in FY2025 5 m CHF of stock-based compensation in the year
  • Capital returned 21 m CHF · 70% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sector × region Health care in Europe: +3.0% week · −4.5% month · −2.1% quarter · −5.0% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-20
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Medacta Group SA (MOVE.SW)?

Medacta Group SA trades as MOVE.SW on the SW exchange (Switzerland) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-19.

Is MOVE.SW in a Closelook index?

Not currently — Medacta Group SA is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

What is Medacta Group SA's Closelook composite score?

47 out of 100, with momentum 10, quality 57 and valuation 32 sub-scores, as of 2026-09-19. Scores are Closelook's own research readings, not ratings or investment advice.

Where does MOVE.SW trade against its moving averages?

Downtrend stack: Trades -15% vs the 50-day and -24.4% vs the 200-day average, 38% below the 52-week high and +1.5% off the 52-week low. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Medacta Group SA do?

Medacta designs, manufactures and distributes orthopaedic and neurosurgical devices, selling into Latin America, North America, Asia-Pacific and the Middle East and Africa. It builds personalised 3D planning tools used in hip, knee, shoulder and joint replacement, sports medicine and spine surgery. The company was founded in 1958 and is based in Castel San Pietro, Switzerland. The diary has not built a peer group for this name; the comparison the market draws is with larger orthopaedic device makers such as Stryker.

Where does Medacta Group SA sit in the AI build-out?

Medacta carries no seat in our Rubin index; it sits in the medical-device sleeve of our wider universe, under the Healthcare sector, rather than in any part of the AI build-out. Medacta holds no index seat in our coverage and no Closelook score has been built for it. It does not appear in the quotes or editions the diary tracks.

Does Medacta Group SA pay a dividend?

Medacta Group SA has paid 1.10 CHF per share over the last twelve months, paid once a year, a trailing yield of 1.01% on the 2026-09-18 close; the last distribution recorded in the price series was 1.10 CHF on 2026-05-07. In fiscal 2025 the company paid 15 m CHF in dividends and bought back 6 m CHF of its own shares, 70% of that year’s free cash flow. The share count rose 0.3% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for MOVE.SW, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.